secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0000950170-24-135890
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo raises up to $6.2M via warrant exercise inducement; issues new warrants at $9.53
--------------------------------------------------------------------------------

- Holders exercise up to 823,544 existing warrants at $7.50/share for ~$6.2M gross proceeds.
- Company issues new warrants to buy 200% of shares exercised at $9.53, 5-year term.
- Roth Capital gets 7% advisory fee; proceeds used for working capital.
- Resale registration statement for new warrant shares due by Dec. 27, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024135890/0000950170-24-135890-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024135890/apvo-20241212.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-135890

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer